Camp Lejeune Lawsuit Symptoms: The Nine Qualifying Diseases

Symptoms that support a Camp Lejeune lawsuit fall into five broad groups: several cancers, Parkinson’s disease and other neurological effects, kidney and liver disease, the autoimmune condition scleroderma, and reproductive or developmental harm. Nine of these illnesses have already been formally accepted by the government for settlement, and they carry the strongest cases. Others can still be pursued, but the scientific evidence tying them to the contaminated water varies. The contamination itself involved four chemicals in the base water supply between August 1953 and December 1987: trichloroethylene (TCE), tetrachloroethylene (PCE), benzene, and vinyl chloride.¹

Who Qualifies to File

To bring a claim under the Camp Lejeune Justice Act, a person had to have lived, worked, or otherwise been exposed to the water at Camp Lejeune or MCAS New River for at least 30 days between August 1, 1953, and December 31, 1987.² That covers veterans, civilian employees, family members who lived on base, and individuals exposed in utero.³ Executors or legal representatives can file on behalf of someone who has died or become incapacitated.⁴

One boundary matters before going further: the filing deadline was August 10, 2024, and the Navy is no longer accepting new administrative claims.⁵ The information below applies to claimants who filed before that date and are still moving through the settlement or litigation process.

The Nine Diseases in the Government’s Settlement Program

The Department of Justice announced the Elective Option settlement program in September 2023, and it covers nine specific illnesses grouped into two tiers based on how strong the scientific link is. These are the diseases with the clearest path to compensation.⁶

Tier 1 diseases carry the strongest evidence and the higher payouts:

Kidney cancer
Liver cancer
Non-Hodgkin lymphoma
Leukemia
Bladder cancer

Tier 2 diseases:

Multiple myeloma
Parkinson’s disease
Kidney disease, including end-stage renal disease
Systemic sclerosis (scleroderma)⁶

Lawsuits are not limited to this list. A claimant can pursue compensation for any illness they can link to the contaminated water, but if the diagnosis is outside the nine above, the case has to be proven through litigation rather than the streamlined settlement track.

Cancers Linked to the Water

Cancer claims are the core of the litigation. The Agency for Toxic Substances and Disease Registry (ATSDR) found “sufficient evidence” of a causal relationship between the water and five cancers: kidney cancer (from TCE), bladder cancer (from PCE), liver cancer (from vinyl chloride), leukemia (from benzene), and non-Hodgkin lymphoma (from TCE and benzene). Multiple myeloma sits at a slightly lower “equipoise and above” level of evidence, meaning the science supports a link but falls short of definitive causation.⁷

Beyond those, lawsuits allege connections to breast, lung, esophageal, brain, cervical, ovarian, pancreatic, prostate, and rectal cancers as well as soft tissue cancers. ATSDR research has found positive associations for several of these in at least one study, though the evidence is weaker than for the diseases in the settlement tiers.⁷

Parkinson’s Disease and Other Neurological Symptoms

Parkinson’s is the most prominent non-cancer condition in the litigation. A VA study of roughly 172,000 veterans stationed at Camp Lejeune between 1975 and 1985 compared them to a similar-sized cohort at Camp Pendleton and found a 70 percent higher risk of developing Parkinson’s decades later, with TCE identified as the likely driver.⁸

A 2024 study in Movement Disorders looked at 270 people who developed Parkinson’s after serving at the base and found that those with volatile organic compound exposure had faster disease progression and elevated risks for psychosis, falls, and fractures. Falls followed a statistically significant dose-response trend: higher exposure meant an earlier fall.⁹

Symptoms that fall short of a Parkinson’s diagnosis but are still tied to solvent exposure include fatigue, lack of coordination, confusion, depression, difficulty concentrating, headaches, and sensory disturbances. Researchers have documented deficits in memory, reaction time, color discrimination, and contrast sensitivity in people exposed to TCE and PCE.¹⁰

Kidney and Liver Disease

Chronic kidney disease and end-stage renal disease both qualify. ATSDR research found that exposure to TCE and PCE raised the risk of both kidney cancer and chronic kidney disease, with risk climbing at higher exposure levels.¹¹ Signs can include decreased kidney function, protein in the urine, and elevated blood urea nitrogen. At higher acute doses, TCE and PCE can cause tubular damage severe enough to impair the kidneys’ ability to filter and reabsorb.¹²

Hepatic steatosis, or fatty liver disease, is on the VA’s list of covered conditions. TCE and PCE cause lipids to build up in liver cells, triggering inflammation that can progress to fibrosis, cirrhosis, and eventually liver cancer.¹³ Most people with fatty liver disease have no symptoms. Some report fatigue or pain in the upper right abdomen, about half present with an enlarged liver, and elevated liver enzymes on routine blood work often provide the first clue.¹⁴

Scleroderma

Systemic sclerosis, better known as scleroderma, is an autoimmune condition in which the body overproduces collagen, causing scarring and hardening of the skin, joints, and internal organs.¹⁵ TCE exposure can trigger autoimmune responses by altering T-cell function, and people exposed during gestation and early life may be particularly vulnerable.¹⁶

Early symptoms typically include puffy fingers, tightening skin on the fingertips, and Raynaud syndrome, where fingers turn pale, numb, or painful in the cold. As the disease progresses it can cause heartburn, difficulty swallowing, shortness of breath, and damage to the lungs, heart, and kidneys.¹⁵ ATSDR classifies the TCE-scleroderma link at “equipoise and above.”⁷

Reproductive Harm and Birth Defects

The VA recognizes female infertility and miscarriage as qualifying conditions for Camp Lejeune health care benefits.¹⁷ An ATSDR study of children born between 1968 and 1985 to mothers exposed to the water found that first-trimester exposure to TCE and benzene was linked to a higher risk of neural tube defects such as spina bifida, with the risk rising alongside higher TCE levels. The same study found weaker associations between first-trimester exposure to PCE and vinyl chloride and childhood leukemia and non-Hodgkin lymphoma, though those risks did not climb with higher exposure.¹⁸ Cardiac birth defects, which ATSDR classifies as having “sufficient evidence” of a link to TCE, are also alleged in lawsuits.⁷

VA Presumptive Conditions Are Not the Same as Lawsuit Qualifying Diseases

The VA and the lawsuit process use overlapping but different lists. For VA disability compensation, the VA presumes service connection for eight diseases, so veterans don’t have to individually prove causation:

Adult leukemia
Aplastic anemia and other myelodysplastic syndromes
Bladder cancer
Kidney cancer
Liver cancer
Multiple myeloma
Non-Hodgkin lymphoma
Parkinson’s disease²

The VA also provides cost-free health care for a broader set of 15 conditions, adding breast cancer, esophageal cancer, lung cancer, hepatic steatosis, female infertility, miscarriage, neurobehavioral effects, renal toxicity, and scleroderma.¹⁷ Qualifying for VA benefits does not automatically qualify a lawsuit claim, and vice versa; the two systems evaluate the same evidence under different standards.

How Qualifying Diseases Translate Into Compensation

For claimants whose disease is on the Elective Option list, the settlement amount depends on the tier and how long they were at Camp Lejeune:

Tier 1 cancers (kidney, liver, non-Hodgkin lymphoma, leukemia, bladder): $150,000 for 30 to 364 days of exposure, $300,000 for one to five years, and $450,000 for more than five years.
Tier 2 diseases (multiple myeloma, Parkinson’s, kidney disease/end-stage renal disease, scleroderma): $100,000 for 30 to 364 days, $250,000 for one to five years, and $400,000 for more than five years.
If the qualifying injury caused the claimant’s death, the offer increases by $100,000, bringing the maximum possible settlement to $550,000.⁶

The Elective Option covers only one qualifying injury per claimant, whichever pays the most. Its payments are not reduced by VA disability awards or Medicare fee-for-service benefits, unlike potential litigation awards.⁴

As of February 2026, the Navy had approved 2,353 Elective Option offers on administrative claims, and 1,605 had been accepted. On the litigation side, 105 offers had been accepted out of 178 cases meeting the criteria. Total payments across both tracks had reached $469.4 million, with the total value of approved offers exceeding $691.3 million.¹⁹ Court-appointed settlement masters are also developing a broader matrix that would categorize claims by injury severity, exposure duration, and medical evidence, with a draft framework possibly emerging in 2026.²⁰ Claimants with diseases outside the nine Elective Option conditions will typically wait for that matrix or for their case to move through litigation.

1
ATSDR. Chemicals Involved in Camp Lejeune Contamination
2
Department of Veterans Affairs. Camp Lejeune Water Contamination Eligibility
3
Triage Cancer. Camp Lejeune Act Quick Guide
4
Department of Justice. Camp Lejeune Justice Act Claims
5
Department of the Navy. Camp Lejeune Justice Act
6
Department of the Navy. Public Guidance on the Elective Option for CLJA Claims
7
ATSDR. Health Effects Linked With TCE, PCE, Benzene, and Vinyl Chloride
8
Department of Veterans Affairs. Camp Lejeune Research
9
Movement Disorders. Progression of Parkinson’s Disease Among Camp Lejeune Veterans
10
National Library of Medicine. Contaminated Water Supplies at Camp Lejeune, Neurobehavioral Effects
11
ATSDR. Morbidity Study of Former Marines, Employees, and Dependents
12
National Library of Medicine. Contaminated Water Supplies at Camp Lejeune, Renal Toxicity
13
National Academies Press. Contaminated Water Supplies at Camp Lejeune, Hepatotoxicity
14
National Library of Medicine. Contaminated Water Supplies at Camp Lejeune, Hepatic Steatosis
15
Merck Manuals. Systemic Sclerosis
16
National Library of Medicine. TCE and Autoimmunity in Early Life
17
Department of Veterans Affairs. Camp Lejeune Exposure Information
18
ATSDR. Birth Defects and Childhood Cancers Study
19
Camp Lejeune Lien Resolution. CLJA Settlement Status Update, February 2026
20
Camp Lejeune Government and Court Affairs. Camp Lejeune Water Litigation March 2026 Update